Skip to main content
Top
Published in: Inflammation 2/2016

01-04-2016 | ORIGINAL ARTICLE

The Effects of Quercetin on Acute Lung Injury and Biomarkers of Inflammation and Oxidative Stress in the Rat Model of Sepsis

Authors: Fethullah Gerin, Umit Sener, Hayriye Erman, Ahsen Yilmaz, Bayram Aydin, Ferah Armutcu, Ahmet Gurel

Published in: Inflammation | Issue 2/2016

Login to get access

Abstract

Experimental studies indicate that sepsis causes remote organ injury although the molecular mechanism has not been clearly defined. In this report, the role of oxidative damage, and inflammation on lung injury, following sepsis model by cecal ligation and puncture, and the effects of quercetin, antioxidant, and anti-inflammatory flavonoid, in the lung tissue were investigated. In the present study, we found that administration of single-dose quercetin before cecal ligation and puncture procedure, while markedly diminishing the levels of YKL-40 and oxidant molecules (xanthine oxidase (XO), nitric oxide (NO), and malondialdehyde (MDA)), increases the antioxidant enzymes levels. Quercetin is beneficial to acute lung injury by decreasing the levels of oxidative stress markers and increasing the antioxidant enzyme activities. Quercetin also causes a decrease in the serum levels of YKL-40 and periostin in the oxidative lung injury induced by the experimental sepsis model.
Literature
1.
go back to reference Martin, G.S. 2012. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Review of Anti-Infective Therapy 10(6): 701–6.CrossRefPubMedPubMedCentral Martin, G.S. 2012. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Review of Anti-Infective Therapy 10(6): 701–6.CrossRefPubMedPubMedCentral
2.
go back to reference Wang, L., J. Chen, B. Wang, D. Wu, and H. Li. 2014. Protective effect of quercetin on lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammatory cell influx. Experimental Biology and Medicine 239(12): 1653–1662.CrossRefPubMed Wang, L., J. Chen, B. Wang, D. Wu, and H. Li. 2014. Protective effect of quercetin on lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammatory cell influx. Experimental Biology and Medicine 239(12): 1653–1662.CrossRefPubMed
3.
go back to reference Huang, R., T. Zhong, and H. Wu. 2015. Quercetin protects against lipopolysaccharide-induced acute lung injury in rats through suppression of inflammation and oxidative stress. Archives of Medical Science 11(2): 427–432.CrossRefPubMedPubMedCentral Huang, R., T. Zhong, and H. Wu. 2015. Quercetin protects against lipopolysaccharide-induced acute lung injury in rats through suppression of inflammation and oxidative stress. Archives of Medical Science 11(2): 427–432.CrossRefPubMedPubMedCentral
5.
go back to reference Osuchowski, M.F., J. Connett, K. Welch, J. Granger, and D.G. Remick. 2009. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Critical Care Medicine 37(5): 1567–1573.CrossRefPubMedPubMedCentral Osuchowski, M.F., J. Connett, K. Welch, J. Granger, and D.G. Remick. 2009. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Critical Care Medicine 37(5): 1567–1573.CrossRefPubMedPubMedCentral
6.
go back to reference Hattori, N., S. Oda, T. Sadahiro, M. Nakamura, and R. Abe. 2009. YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock 32(4): 393–400.CrossRefPubMed Hattori, N., S. Oda, T. Sadahiro, M. Nakamura, and R. Abe. 2009. YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock 32(4): 393–400.CrossRefPubMed
7.
go back to reference DeCoux, A., Y. Tian, K.Y. DeLeon-Pennell, N.T. Nguyen, L.E. de Castro Brás, E.R. Flynn, et al. 2015. Plasma glycoproteomics reveals sepsis outcomes linked to distinct proteins in common pathways. Critical Care Medicine 43(10): 2049–2058.CrossRefPubMed DeCoux, A., Y. Tian, K.Y. DeLeon-Pennell, N.T. Nguyen, L.E. de Castro Brás, E.R. Flynn, et al. 2015. Plasma glycoproteomics reveals sepsis outcomes linked to distinct proteins in common pathways. Critical Care Medicine 43(10): 2049–2058.CrossRefPubMed
8.
go back to reference Luangaram, S., U. Kukongviriyapan, P. Pakdeechote, V. Kukongviriyapan, and P. Pannangpetch. 2007. Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats. Food and Chemical Toxicology 45(3): 448–455.CrossRefPubMed Luangaram, S., U. Kukongviriyapan, P. Pakdeechote, V. Kukongviriyapan, and P. Pannangpetch. 2007. Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats. Food and Chemical Toxicology 45(3): 448–455.CrossRefPubMed
9.
go back to reference Ganesan, S., A.N. Faris, A.T. Comstock, S.S. Chattoraj, and A. Chattoraj. 2010. Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respiratory Research 11(131): 1–15. Ganesan, S., A.N. Faris, A.T. Comstock, S.S. Chattoraj, and A. Chattoraj. 2010. Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respiratory Research 11(131): 1–15.
10.
go back to reference Conway, S.J., K. Izuhara, Y. Kudo, J. Litvin, and R. Markwald. 2014. The role of periostin in tissue remodeling across health and disease. Cellular and Molecular Life Sciences 71: 1279–1288.CrossRefPubMedPubMedCentral Conway, S.J., K. Izuhara, Y. Kudo, J. Litvin, and R. Markwald. 2014. The role of periostin in tissue remodeling across health and disease. Cellular and Molecular Life Sciences 71: 1279–1288.CrossRefPubMedPubMedCentral
11.
go back to reference Li, W., P. Gao, Y. Zhi, W. Xu, Y. Wu, J. Yin, et al. 2015. Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respiratory Research 16(1): 57.CrossRefPubMedPubMedCentral Li, W., P. Gao, Y. Zhi, W. Xu, Y. Wu, J. Yin, et al. 2015. Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respiratory Research 16(1): 57.CrossRefPubMedPubMedCentral
12.
go back to reference Dejager, L., I. Pinheiro, E. Dejonckheere, and C. Libert. 2011. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends in Microbiology 19(4): 198–208.CrossRefPubMed Dejager, L., I. Pinheiro, E. Dejonckheere, and C. Libert. 2011. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends in Microbiology 19(4): 198–208.CrossRefPubMed
13.
go back to reference Wichterman, K.A., A.E. Baue, and I.H. Chaudry. 1980. Sepsis and septic shock—a review of laboratory models and a proposal. Journal of Surgical Research 29: 189–201.CrossRefPubMed Wichterman, K.A., A.E. Baue, and I.H. Chaudry. 1980. Sepsis and septic shock—a review of laboratory models and a proposal. Journal of Surgical Research 29: 189–201.CrossRefPubMed
14.
go back to reference Hubbard, W.J., M. Choudhry, M.G. Schwacha, and J.D. Kerby. 2005. Cecal ligation and puncture. Shock 24: 52–57.CrossRefPubMed Hubbard, W.J., M. Choudhry, M.G. Schwacha, and J.D. Kerby. 2005. Cecal ligation and puncture. Shock 24: 52–57.CrossRefPubMed
15.
go back to reference Prajda, N., and G. Weber. 1975. Malign transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Letters 59: 245–249.CrossRefPubMed Prajda, N., and G. Weber. 1975. Malign transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Letters 59: 245–249.CrossRefPubMed
16.
go back to reference Sun, Y., L.W. Oberley, and Y. Li. 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34: 497–500.PubMed Sun, Y., L.W. Oberley, and Y. Li. 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34: 497–500.PubMed
17.
go back to reference Aebi H. Catalase. Methods Enzym. Anal. New York and London: Academic Press; 1974;673–677. Aebi H. Catalase. Methods Enzym. Anal. New York and London: Academic Press; 1974;673–677.
18.
go back to reference Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265–275.PubMed Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265–275.PubMed
19.
go back to reference Liao, Y.R., and J.Y. Lin. 2015. Quercetin intraperitoneal administration ameliorates lipopolysaccharide-induced systemic inflammation in mice. Life Sciences 137(15): 89–97.CrossRefPubMed Liao, Y.R., and J.Y. Lin. 2015. Quercetin intraperitoneal administration ameliorates lipopolysaccharide-induced systemic inflammation in mice. Life Sciences 137(15): 89–97.CrossRefPubMed
20.
go back to reference Chang, Y.C., M.H. Tsai, W.H. Sheu, S.C. Hsieh, and A.N. Chiang. 2013. The therapeutic potential and mechanisms of action of quercetin in relation to lipopolysaccharide-induced sepsis in vitro and in vivo. PloS One 8(11), e80744.CrossRefPubMedPubMedCentral Chang, Y.C., M.H. Tsai, W.H. Sheu, S.C. Hsieh, and A.N. Chiang. 2013. The therapeutic potential and mechanisms of action of quercetin in relation to lipopolysaccharide-induced sepsis in vitro and in vivo. PloS One 8(11), e80744.CrossRefPubMedPubMedCentral
21.
go back to reference Kukongviriyapan, U., K. Sompamit, P. Pannagpetch, V. Kukongviriyapan, and W. Donpunha. 2012. Preventive and therapeutic effects of quercetin on lipopolysaccharide-induced oxidative stress and vascular dysfunction in mice. Canadian Journal of Physiology and Pharmacology 90(10): 1345–1353.CrossRefPubMed Kukongviriyapan, U., K. Sompamit, P. Pannagpetch, V. Kukongviriyapan, and W. Donpunha. 2012. Preventive and therapeutic effects of quercetin on lipopolysaccharide-induced oxidative stress and vascular dysfunction in mice. Canadian Journal of Physiology and Pharmacology 90(10): 1345–1353.CrossRefPubMed
22.
go back to reference Czapski, G.A., D. Avram, D.V. Sakharov, K.W. Wirtz, J.B. Strosznajder, and E.H. Pap. 2002. Activated neutrophils oxidize extracellular proteins of endothelial cells in culture: effect of nitric oxide donors. Biochemical Journal 365: 897–902.CrossRefPubMedPubMedCentral Czapski, G.A., D. Avram, D.V. Sakharov, K.W. Wirtz, J.B. Strosznajder, and E.H. Pap. 2002. Activated neutrophils oxidize extracellular proteins of endothelial cells in culture: effect of nitric oxide donors. Biochemical Journal 365: 897–902.CrossRefPubMedPubMedCentral
23.
go back to reference Johansen, J.S., K.S. Krabbe, K. Møller, and B.K. Pedersen. 2005. Circulating YKL-40 levels during human endotoxaemia. Clinical and Experimental Immunology 140: 343–348.CrossRefPubMedPubMedCentral Johansen, J.S., K.S. Krabbe, K. Møller, and B.K. Pedersen. 2005. Circulating YKL-40 levels during human endotoxaemia. Clinical and Experimental Immunology 140: 343–348.CrossRefPubMedPubMedCentral
24.
go back to reference Van Bilsen, J.H.M., H. van Dongen, L.R. Lard, E.I.H. van der Voort, D.G. Elferink, A.M. Bakker, et al. 2004. Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. Proceedings of the National Academy of Sciences 101: 17180–17185.CrossRef Van Bilsen, J.H.M., H. van Dongen, L.R. Lard, E.I.H. van der Voort, D.G. Elferink, A.M. Bakker, et al. 2004. Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. Proceedings of the National Academy of Sciences 101: 17180–17185.CrossRef
25.
go back to reference Kronborg, G., C. Østergaard, N. Weis, H. Nielsen, and N. Obel. 2002. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scandinavian Journal of Infectious Diseases 34: 323–326.CrossRefPubMed Kronborg, G., C. Østergaard, N. Weis, H. Nielsen, and N. Obel. 2002. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scandinavian Journal of Infectious Diseases 34: 323–326.CrossRefPubMed
26.
go back to reference Huang, Y., W. Liu, H. Xiao, A. Maitikabili, Q. Lin, T. Wu, et al. 2015. Matricellular protein periostin contributes to hepatic inflammation and fibrosis. American Journal of Pathology 185(3): 786–797.CrossRefPubMed Huang, Y., W. Liu, H. Xiao, A. Maitikabili, Q. Lin, T. Wu, et al. 2015. Matricellular protein periostin contributes to hepatic inflammation and fibrosis. American Journal of Pathology 185(3): 786–797.CrossRefPubMed
27.
go back to reference Takayama, G., K. Arima, T. Kanaji, S. Toda, H. Tanaka, S. Shoji, et al. 2006. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. Journal of Allergy and Clinical Immunology 118: 98–104.CrossRefPubMed Takayama, G., K. Arima, T. Kanaji, S. Toda, H. Tanaka, S. Shoji, et al. 2006. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. Journal of Allergy and Clinical Immunology 118: 98–104.CrossRefPubMed
Metadata
Title
The Effects of Quercetin on Acute Lung Injury and Biomarkers of Inflammation and Oxidative Stress in the Rat Model of Sepsis
Authors
Fethullah Gerin
Umit Sener
Hayriye Erman
Ahsen Yilmaz
Bayram Aydin
Ferah Armutcu
Ahmet Gurel
Publication date
01-04-2016
Publisher
Springer US
Published in
Inflammation / Issue 2/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-015-0296-9

Other articles of this Issue 2/2016

Inflammation 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.